Literature DB >> 1527848

A novel oncogene, v-ryk, encoding a truncated receptor tyrosine kinase is transduced into the RPL30 virus without loss of viral sequences.

R Jia1, B J Mayer, T Hanafusa, H Hanafusa.   

Abstract

The RPL viruses are acute oncogenic avian retroviruses isolated from chicken tumors. We carried out a genetic analysis of three of the viruses, RPL25, RPL28, and RPL30. While RPL25 and RPL28 were shown to contain the erbB oncogene, RPL30 appeared to contain a novel protein tyrosine kinase oncogene. This gene, v-ryk, was cloned and sequenced. The v-ryk oncogene contains a 1.39-kb nonretroviral sequence that includes a tyrosine kinase domain which was inserted into the viral envelope protein gp37-coding region and fused in frame with upstream gp37 to generate a P69gp37-ryk fusion oncoprotein. Unlike that of other acutely transforming retroviruses, transduction of the v-ryk gene into RPL30 did not result in deletion of viral sequences. Sequence analysis suggested that v-Ryk is more homologous to receptor-type tyrosine kinases than to nonreceptor-type kinases. By reconstitution of a virus from its cDNA, the v-ryk oncogene has been shown to be fully responsible for the transforming activity of the RPL30 virus. Antibodies specific to v-Ryk immunoprecipitated the v-Ryk oncoprotein from cells transformed by the RPL30 virus. The v-Ryk protein was shown to be first synthesized as a 150-kDa precursor and then cleaved into the mature 69-kDa gp37-Ryk fusion protein, both parts of which were found to be localized to the membrane fraction. As expected from the sequence of v-Ryk, immunoprecipitates of v-Ryk from RPL30-transformed cells were found to display a protein tyrosine kinase activity in vitro, and the levels of tyrosine-phosphorylated proteins are elevated in v-ryk-transformed cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527848      PMCID: PMC241475     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Intracellular precursors to the major glycoprotein of avian oncoviruses in chicken embryo fibroblasts.

Authors:  D L Buchhagen; H Hanafusa
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  A putative receptor tyrosine kinase with unique structural topology.

Authors:  J Rescigno; A Mansukhani; C Basilico
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

4.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.

Authors:  J Downward; Y Yarden; E Mayes; G Scrace; N Totty; P Stockwell; A Ullrich; J Schlessinger; M D Waterfield
Journal:  Nature       Date:  1984 Feb 9-15       Impact factor: 49.962

5.  Sequencing the erbA gene of avian erythroblastosis virus reveals a new type of oncogene.

Authors:  B Debuire; C Henry; M Bernissa; G Biserte; J M Claverie; S Saule; P Martin; D Stehelin
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

6.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

Authors:  J P O'Bryan; R A Frye; P C Cogswell; A Neubauer; B Kitch; C Prokop; R Espinosa; M M Le Beau; H S Earp; E T Liu
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  Genetic structure and transforming sequence of avian sarcoma virus UR2.

Authors:  L H Wang; H Hanafusa; M F Notter; P C Balduzzi
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.

Authors:  E P Reddy; M J Smith; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  A novel putative tyrosine kinase receptor with oncogenic potential.

Authors:  J W Janssen; A S Schulz; A C Steenvoorden; M Schmidberger; S Strehl; P F Ambros; C R Bartram
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

View more
  17 in total

Review 1.  Biology of the TAM receptors.

Authors:  Greg Lemke
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

2.  Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB.

Authors:  M M Georgescu; K H Kirsch; T Shishido; C Zong; H Hanafusa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  A single amino acid substitution in the v-Eyk intracellular domain results in activation of Stat3 and enhances cellular transformation.

Authors:  D Besser; J F Bromberg; J E Darnell; H Hanafusa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 4.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

Review 5.  The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

Authors:  Douglas K Graham; Deborah DeRyckere; Kurtis D Davies; H Shelton Earp
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

Review 6.  Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Authors:  Carla V Rothlin; Jonathan A Leighton; Sourav Ghosh
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

7.  A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.

Authors:  Susan Sather; Karla D Kenyon; Jerry B Lefkowitz; Xiayuan Liang; Brian C Varnum; Peter M Henson; Douglas K Graham
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

8.  Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins.

Authors:  Q K Zhang; S Boast; K de los Santos; M Begemann; S P Goff
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase.

Authors:  C Zong; R Yan; A August; J E Darnell; H Hanafusa
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

Review 10.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.